USD 31.79
(-6.47%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 11.79 Million USD | 1339.42% |
2022 | 819.22 Thousand USD | 92.56% |
2021 | 425.44 Thousand USD | -11.62% |
2020 | 481.38 Thousand USD | -77.07% |
2019 | 2.09 Million USD | 39.93% |
2018 | 1.5 Million USD | 25.0% |
2017 | 1.2 Million USD | -25.84% |
2016 | 1.61 Million USD | -11.25% |
2015 | 1.82 Million USD | 13.52% |
2014 | 1.6 Million USD | 1.33% |
2013 | 1.58 Million USD | -34.48% |
2012 | 2.41 Million USD | 76.85% |
2011 | 1.36 Million USD | -47.0% |
2010 | 2.58 Million USD | 88.99% |
2009 | 1.36 Million USD | -9.44% |
2008 | 1.5 Million USD | 0.0% |
2007 | 1.5 Million USD | 17.72% |
2006 | 1.28 Million USD | 17789.21% |
2005 | 7161.00 USD | -30.69% |
2004 | 10.33 Thousand USD | 0.0% |
2001 | 2.09 Million USD | 140397.66% |
2000 | 1494.00 USD | -99.86% |
1999 | 1.07 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 11.69 Million USD | -0.78% |
2024 Q2 | 16.27 Million USD | 39.13% |
2023 Q2 | 2.05 Million USD | -2.82% |
2023 FY | 11.79 Million USD | 1339.42% |
2023 Q4 | 11.79 Million USD | -0.56% |
2023 Q3 | 11.85 Million USD | 477.65% |
2023 Q1 | 2.11 Million USD | 157.87% |
2022 FY | 819.22 Thousand USD | 92.56% |
2022 Q1 | 367.27 Thousand USD | -13.67% |
2022 Q2 | 308.33 Thousand USD | -16.05% |
2022 Q3 | 866.81 Thousand USD | 181.13% |
2022 Q4 | 819.22 Thousand USD | -5.49% |
2021 FY | 425.44 Thousand USD | -11.62% |
2021 Q1 | 450.46 Thousand USD | -6.42% |
2021 Q2 | 419.05 Thousand USD | -6.97% |
2021 Q4 | 425.44 Thousand USD | -11.89% |
2021 Q3 | 482.85 Thousand USD | 15.23% |
2020 FY | 481.38 Thousand USD | -77.07% |
2020 Q1 | 570.58 Thousand USD | -72.82% |
2020 Q2 | 1.12 Million USD | 97.13% |
2020 Q3 | 1.09 Million USD | -2.66% |
2020 Q4 | 481.38 Thousand USD | -56.03% |
2019 Q4 | 2.09 Million USD | -49.11% |
2019 Q1 | 2.22 Million USD | 48.52% |
2019 Q3 | 4.12 Million USD | 52.49% |
2019 Q2 | 2.7 Million USD | 21.4% |
2019 FY | 2.09 Million USD | 39.93% |
2018 Q1 | - USD | -100.0% |
2018 Q3 | 1.5 Million USD | 0.0% |
2018 Q4 | 1.5 Million USD | 0.0% |
2018 FY | 1.5 Million USD | 25.0% |
2018 Q2 | - USD | 0.0% |
2017 Q2 | 1.42 Million USD | -7.72% |
2017 Q3 | 1.42 Million USD | -0.08% |
2017 FY | 1.2 Million USD | -25.84% |
2017 Q1 | 1.54 Million USD | -4.57% |
2017 Q4 | 1.2 Million USD | -15.72% |
2016 Q1 | 1.76 Million USD | -3.41% |
2016 FY | 1.61 Million USD | -11.25% |
2016 Q2 | 1.69 Million USD | -3.52% |
2016 Q4 | 1.61 Million USD | -1.75% |
2016 Q3 | 1.64 Million USD | -3.07% |
2015 Q4 | 1.82 Million USD | -2.83% |
2015 Q2 | 1.89 Million USD | 18.12% |
2015 Q1 | 1.6 Million USD | -0.13% |
2015 FY | 1.82 Million USD | 13.52% |
2015 Q3 | 1.87 Million USD | -0.97% |
2014 FY | 1.6 Million USD | 1.33% |
2014 Q2 | 1.58 Million USD | 0.37% |
2014 Q1 | 1.58 Million USD | -0.26% |
2014 Q4 | 1.6 Million USD | 0.84% |
2014 Q3 | 1.59 Million USD | 0.37% |
2013 FY | 1.58 Million USD | -34.48% |
2013 Q3 | 2.57 Million USD | 5.21% |
2013 Q4 | 1.58 Million USD | -38.5% |
2013 Q1 | 2.41 Million USD | -0.22% |
2013 Q2 | 2.44 Million USD | 1.48% |
2012 FY | 2.41 Million USD | 76.85% |
2012 Q2 | 2.01 Million USD | -17.46% |
2012 Q3 | 2.43 Million USD | 21.28% |
2012 Q4 | 2.41 Million USD | -0.8% |
2012 Q1 | 2.43 Million USD | 78.09% |
2011 Q3 | 1.65 Million USD | -31.99% |
2011 Q4 | 1.36 Million USD | -17.11% |
2011 FY | 1.36 Million USD | -47.0% |
2011 Q2 | 2.42 Million USD | 40.85% |
2011 Q1 | 1.72 Million USD | -33.25% |
2010 FY | 2.58 Million USD | 88.99% |
2010 Q3 | 3 Million USD | 10.32% |
2010 Q4 | 2.58 Million USD | -14.2% |
2010 Q1 | 2.46 Million USD | 80.24% |
2010 Q2 | 2.72 Million USD | 10.78% |
2009 FY | 1.36 Million USD | -9.44% |
2009 Q4 | 1.36 Million USD | 42.58% |
2009 Q3 | 957.85 Thousand USD | 54.47% |
2009 Q2 | 620.07 Thousand USD | 16.36% |
2009 Q1 | 532.9 Thousand USD | 0.0% |
2008 Q1 | 924.38 Thousand USD | -38.7% |
2008 Q4 | - USD | -100.0% |
2008 Q3 | 915.08 Thousand USD | -11.82% |
2008 Q2 | 1.03 Million USD | 12.27% |
2008 FY | 1.5 Million USD | 0.0% |
2007 Q2 | 1.36 Million USD | 5.3% |
2007 Q3 | 1.36 Million USD | 0.16% |
2007 FY | 1.5 Million USD | 17.72% |
2007 Q4 | 1.5 Million USD | 10.12% |
2007 Q1 | 1.29 Million USD | 1.36% |
2006 Q1 | 7313.00 USD | 2.12% |
2006 Q2 | 5215.00 USD | -28.69% |
2006 Q4 | 1.28 Million USD | 30459.3% |
2006 Q3 | 4192.00 USD | -19.62% |
2006 FY | 1.28 Million USD | 17789.21% |
2005 Q3 | 7262.00 USD | -12.36% |
2005 Q2 | 8286.00 USD | -97.4% |
2005 Q4 | 7161.00 USD | -1.39% |
2005 FY | 7161.00 USD | -30.69% |
2005 Q1 | 318.91 Thousand USD | 2986.62% |
2004 Q2 | 527.5 Thousand USD | 9.09% |
2004 Q3 | 527.5 Thousand USD | 0.0% |
2004 FY | 10.33 Thousand USD | 0.0% |
2004 Q4 | 10.33 Thousand USD | -98.04% |
2004 Q1 | 483.54 Thousand USD | 0.0% |
2002 Q1 | 6741.00 USD | -99.68% |
2001 Q2 | 54.09 Thousand USD | -96.94% |
2001 Q3 | 2.19 Million USD | 3956.79% |
2001 Q4 | 2.09 Million USD | -4.35% |
2001 Q1 | 1.76 Million USD | 118161.04% |
2001 FY | 2.09 Million USD | 140397.66% |
2000 Q4 | 1494.00 USD | -99.9% |
2000 Q1 | 1.18 Million USD | 0.0% |
2000 Q3 | 1.55 Million USD | 6.64% |
2000 FY | 1494.00 USD | -99.86% |
2000 Q2 | 1.46 Million USD | 22.94% |
1999 FY | 1.07 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | 86.241% |
AngioDynamics, Inc. | 5.91 Million USD | -99.393% |
AtriCure, Inc. | 74.49 Million USD | 84.17% |
Avinger, Inc. | 15.39 Million USD | 23.403% |
Azenta, Inc. | 60.43 Million USD | 80.488% |
BioLife Solutions, Inc. | 42.69 Million USD | 72.378% |
The Cooper Companies, Inc. | 2.56 Billion USD | 99.541% |
Daxor Corporation | 755.65 Thousand USD | -1460.507% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -64.51% |
Femasys Inc. | 6.7 Million USD | -75.978% |
GlucoTrack, Inc. | 196 Thousand USD | -5916.383% |
Harvard Bioscience, Inc. | 42.77 Million USD | 72.431% |
Hologic, Inc. | 2.53 Billion USD | 99.535% |
ICU Medical, Inc. | 1.7 Billion USD | 99.308% |
Intuitive Surgical, Inc. | 89.8 Million USD | 86.868% |
KORU Medical Systems, Inc. | 4.44 Million USD | -165.282% |
LeMaitre Vascular, Inc. | 19.09 Million USD | 38.245% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 98.784% |
Microbot Medical Inc. | 231 Thousand USD | -5004.81% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -60.85% |
Merit Medical Systems, Inc. | 891.35 Million USD | 98.677% |
Nephros, Inc. | 1.83 Million USD | -542.272% |
NovoCure Limited | 596.24 Million USD | 98.022% |
NEXGEL, Inc. | 2.79 Million USD | -321.448% |
NEXGEL, Inc. | 2.79 Million USD | -321.448% |
Singular Genomics Systems, Inc. | 75.28 Million USD | 84.337% |
OraSure Technologies, Inc. | 13.5 Million USD | 12.677% |
Pro-Dex, Inc. | 13.54 Million USD | 12.954% |
Pulse Biosciences, Inc. | 9.14 Million USD | -28.96% |
Predictive Oncology Inc. | 2.85 Million USD | -312.771% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -243.347% |
QuidelOrtho Corporation | 2.61 Billion USD | 99.549% |
Repligen Corporation | 711.8 Million USD | 98.343% |
STAAR Surgical Company | 35.83 Million USD | 67.092% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -3347.985% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.487% |
Jin Medical International Ltd. | 4.11 Million USD | -186.703% |